Charlottesville, Virginia, October 24, 2019 – The Foundation is pleased to announce that Narendra (Naren) Sanghvi, PhD, has joined the team in the newly created role of Resident Focused Ultrasound Guru.
Press Releases from SonaCare Medical
“If you build it, he will come” is the famous line that inspired Iowa farmer Ray Kinsella in "Field of Dreams" to build a baseball diamond where his cornfields once stood.
Read more: Industry Voices - If you build it, Medicare coverage should come
5-year Outcomes Following a HIFU Focal Therapy Study Demonstrate Impressive Disease Control & Low Side Effect Profiles For Prostate Cancer Patients In The U.K.
Sonablate® HIFU used in study to treat clinically significant nonmetastatic prostate cancer achieves complete pad-free urinary continence in 98% of men.
SonaCare Medical's CSO, Naren Sanghvi, Receives the William and Francis Fry Award for His Contributions to Therapeutic Ultrasound
SonaCare Medical congratulates Naren Sanghvi on his receipt of The William and Francis Fry Honorary Fellowship for Contributions to Therapeutic Ultrasound
SonaCare Medical Sponsors the Inaugural Focal Therapy Masterclass at Imperial College London
Over 120 urologists gather at Imperial College London to learn new diagnostic techniques and minimally invasive focal approaches for treating prostate cancer.
The HIFU Evaluation and Assessment of Treatment (HEAT) Registry Now Includes Data from Over 100 U.S. Sonablate® Patients
CHARLOTTE, NC (PR NEWSWIRE) APRIL 05, 2018 – SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the enrollment of over 100 patients from the United States into the High Intensity Focused Ultrasound Evaluation and Assessment of Treatment (HEAT) Registry.
SonaCare Medical Reports that CMS Announces Increase to ASC Payment for HIFU Prostate Ablation
Medicare recognizes HIFU prostate ablation as a device-intensive procedure driving new ASC payment going into effect on or after October 1, 2017
CHARLOTTE, N.C., Sept. 20, 2017 /PRNewswire/ -- SonaCare Medical, leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, is pleased to announce an increase in Medicare payment for prostate HIFU ablation in the Ambulatory Surgical Center (ASC) setting.
CHARLOTTE, N.C., August 30, 2017 – SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces today the successful collaboration with BK Ultrasound, achieving compatibility between bkFusion and Sonablate® planning software for the ablation of prostate tissue.
Read more: SONACARE MEDICAL DELIVERS COMPATIBILITY WITH BKFUSION
SonaCare Medical Announces Acceptance of Medicare C-Code application for HIFU Prostate Ablation
C-code goes into effect on July 1, 2017
affording greater opportunity to prostate patients in the United States
Charlotte, NC, May 23, 2017 – SonaCare Medical, leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the imminent reimbursement for HIFU prostate tissue ablation with a newly approved C-code.
Charlotte, NC (PR Newswire) April 11th, 2017 - SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces the launch of an International Sonablate HIFU Registry. The High Intensity Focused Ultrasound Evaluation and Assessment of Treatment (HEAT) Registry will be a globally accessible, web-based, platform for storing HIFU data on patients treated with Sonablate.
Read more: International Sonablate HIFU Prostate Registry Officially Launched
address 10130 Perimeter Pkwy, Suite 410
Charlotte, NC 28216
phone (888) 874-4384
email info@SonaCareMedical.com
workhour Mon - Fri: 9:00 - 5:00